Kyle R. Toth

Family Medicine
2785 E 7th St
Austin, TX 78702

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.

Journal: Cell metabolism
Published: December 07, 2016

Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.

Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.

Journal: Oncotarget
Published: May 12, 2016
Showing 1-2 of 2

Last Updated: 09/26/2026